These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29440162)

  • 1. Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.
    Alene KA; Clements ACA; McBryde ES; Jaramillo E; Lonnroth K; Shaweno D; Viney K
    BMJ Open; 2018 Feb; 8(2):e019593. PubMed ID: 29440162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis.
    Akalu TY; Clements ACA; Baraki AG; Alene KA
    PLoS One; 2023; 18(5):e0285404. PubMed ID: 37186609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of multidrug-resistant tuberculosis and its medications on adverse maternal and perinatal outcomes: protocol for a systematic review and meta-analysis.
    Alene KA; Adane AA; Jegnie A
    BMJ Open; 2019 Dec; 9(12):e034821. PubMed ID: 31843857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis.
    Alemu A; Bitew ZW; Diriba G; Gashu E; Seid G; Eshetu K; Kebede A; Gumi B
    BMJ Open; 2023 Apr; 13(4):e070143. PubMed ID: 37019479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of therapeutic outcomes of multidrug resistant tuberculosis and their predictors in adults receiving integrated treatment of tuberculosis and human immuno-deficiency virus in low- and middle-income countries: a study protocol.
    Kadia BM; Aroke D; Njefi KP; Tochie JN; Tianyi FL; Kadia RS; Dimala CA
    Syst Rev; 2020 Oct; 9(1):228. PubMed ID: 33023668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    Alene KA; Clements ACA; McBryde ES; Jaramillo E; Lönnroth K; Shaweno D; Gulliver A; Viney K
    J Infect; 2018 Nov; 77(5):357-367. PubMed ID: 30036607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.
    Sultana ZZ; Hoque FU; Beyene J; Akhlak-Ul-Islam M; Khan MHR; Ahmed S; Hawlader DH; Hossain A
    BMC Infect Dis; 2021 Jan; 21(1):51. PubMed ID: 33430786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
    Tola HH; Holakouie-Naieni K; Lejisa T; Mansournia MA; Yaseri M; Tesfaye E; Mola M
    PLoS One; 2019; 14(6):e0218487. PubMed ID: 31211809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis.
    Tegegne BS; Habtewold TD; Mengesha MM; Burgerhof JG
    Syst Rev; 2017 Jan; 6(1):6. PubMed ID: 28088237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.
    Nellums LB; Rustage K; Hargreaves S; Friedland JS
    BMC Med; 2018 Feb; 16(1):27. PubMed ID: 29466983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis.
    Harris RC; Khan MS; Martin LJ; Allen V; Moore DA; Fielding K; Grandjean L;
    BMC Infect Dis; 2016 Jun; 16():262. PubMed ID: 27283524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Akalu TY; Clements ACA; Wolde HF; Alene KA
    EClinicalMedicine; 2023 Mar; 57():101900. PubMed ID: 36942158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global prevalence of diabetes mellitus in patients with tuberculosis: a systematic review and meta-analysis protocol.
    Tankeu AT; Bigna JJ; Nansseu JR; Endomba FTA; Wafeu GS; Kaze AD; Noubiap JJ
    BMJ Open; 2017 Jun; 7(6):e015170. PubMed ID: 28601832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of community-based directly observed treatment (DOT) versus health facility-based DOT of tuberculosis in Africa: protocol for a systematic review and meta-analysis.
    Baye T; Kassaw AT; Gebrie D; Girmaw F; Ashagrie G
    BMJ Open; 2024 May; 14(5):e081767. PubMed ID: 38724061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of drug-resistant tuberculosis among contacts of index cases: a protocol for a systematic review.
    Akalu TY; Clements ACA; Gebreyohannes EA; Wolde HF; Shiferaw FW; Alene KA
    BMJ Open; 2024 Jan; 14(1):e074364. PubMed ID: 38195168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis.
    Xu G; Hu X; Lian Y; Li X
    BMC Infect Dis; 2023 Nov; 23(1):813. PubMed ID: 37986146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.